Web News Insider
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
As Joe Biden scales back public appearances due to metastatic prostate cancer, we examine the clinical realities of high-risk disease and current…
-
Inside AbbVie’s High-Stakes Neuro Portfolio and Pipeline Strategy
Following recent neuro-pharmaceutical acquisitions and drug approvals, we assess AbbVie’s pipeline strategy, financial impact, and key shareholder risks.
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
Genfit advances TREM-1 modulator into ACLF after prior Phase 2 trials showed safety signals in septic shock and severe COVID-19.
-
How Ueno Bank’s Collapse Toppled Paraguay’s President and Shook Financial Trust
A digital lender serving 60% of adults failed amid insider-lending allegations, triggering a deposit freeze, mass protests, and the impeachment of President…
-
Why Insurers Send Their Own Nurses to Deny Long-Term Care Claims
After 23 years of premiums, a policyholder’s doctor confirmed she needed help bathing and dressing, but an insurer’s nurse scored her as…
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
Large population study finds SABR linked to higher three-year mortality than surgery, but gap narrows significantly for patients 80 and older.
-
Bristol Myers Squibb vs Vertex: Investment Merits Compared Ahead of 2027
Analysis of financial performance and sector trends pits steady value Bristol Myers Squibb against high-growth Vertex Pharmaceuticals for personal finance readers ahead…
-
The $1,500-a-Year GLP-1 Drug Threat to Retirement Savings
Half of GLP-1 users face choosing medication over retirement savings as out-of-pocket costs top $1,500 annually.
-
Lenacapavir PrEP Costs $42,250 a Year in the U.S. Versus $60 for Generic Pills
The twice-yearly injection keeps 86% of users adherent versus 46% for daily pills, but the wholesale price gap exceeds $42,000 annually for…
-
FDA Approves First Antisense Drug Offering Finite Hepatitis B Therapy
Hibsago (bepirovirsen) enables a six-month treatment course that can yield a functional cure, letting some patients stop all antiviral medication.
-
Star Health’s ₹780 Crore Cancer Payouts Signal Rising Claims Burden for Policyholders
Insurer settles 85,900 cancer claims in H1 FY27, with women and the 51-60 age group driving a 17% surge in payouts.
-
How Missing Bank Statements Trigger Medicaid Denials and $41,000 Bills for Nursing Home Residents
A nursing home files a Medicaid application as a courtesy but omits three bank statements, leaving the family liable for four months…
-
Study Finds Autistic Adults Over 45 Face Nearly Triple Parkinsonism Rates
A U.S. Medicare analysis shows Parkinsonism prevalence of 3.8% in autistic seniors versus 1.6% in peers, highlighting new neurodegenerative risks for the…
-
Why Former Firefighters Face Lingering Psychological Trauma After Leaving the Career
An exploration of how leaving high-stress emergency services impacts mental health, reopening deep psychological wounds during secondary trauma events.
-
Overcoming Immunotherapy Resistance Takes Center Stage at SITC 2026
Researchers at the SITC annual meeting tackle major cancer immunotherapy challenges, from metabolic resistance mechanisms to novel combination trials.
-
Retirees Can Sidestep New Senior Deduction Cliff by Using Roth Withdrawals
A 2026 tax rule phases out a $12,000 deduction for couples earning over $150,000, but tax-free Roth IRA distributions do not count…
-
How Amivantamab’s Dual EGFR-MET Blockade Overcomes Resistance in Head and Neck Cancer
The first new drug in a decade for advanced HNSCC uses a bispecific antibody to hit two escape pathways at once, doubling…
-
Claude’s New Personal Finance Tool Lets Users Spot Spending Leaks via Chat
Anthropic’s new feature connects to bank accounts via Plaid, allowing users to ask conversational questions to categorize spending and flag duplicate charges.
-
Why ACA Premiums Are Rising Again in 2027
Double-digit premium hikes return as federal subsidies expire and healthcare costs climb, leaving middle-income families facing higher bills and fewer options.
-
Bank of England Raises Interest Rate
The Bank of England raises interest rates to 4% to control rising inflation driven by global energy prices
-
START Opens First Italian Early-Phase Cancer Trial Site in Rome
Strategic partnership establishes first START site in Italy, expanding early-phase cancer trial access to patients in Rome and the Lazio region despite…
-
Personalized TMS Shows Promise for Severe OCD in Singapore Study
NUH and NUS Medicine report early success using fMRI-guided stimulation for treatment-resistant OCD, aiming to extend the method to depression and anxiety.
-
How a $310,000 Investment Gain Can Boost Medicare Premiums for Retirees
A retiree’s capital gains from selling investments can trigger higher Medicare Part B premiums two years later, a surprise cost many overlook.
-
Inovio’s First FDA Approval Tests Whether DNA Medicines Can Pay Off for Retail Investors
Voceryq’s accelerated approval for a rare throat disease gives the Plymouth Meeting biotech its first product revenue, but confirmatory trials and a…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992